Zambia Signs $1.5 Billion US Health Deal After Data Privacy Dispute

Zambia has signed a five year, $1.5 billion health financing agreement with the United States after resolving disputes over patient data privacy and the sharing of biological specimens. Health Minister Roma Chilengi said data sharing would be limited to information needed to monitor and evaluate US funded programmes. The combined contribution from both countries is expected to reach $3.6 billion. Zambia also confirmed that negotiations over its mineral resources would take place separately. The agreement comes amid a wider US policy shift requiring African countries to gradually increase domestic health spending as American assistance is phased out.

Zambia has signed a $1.5 billion health financing agreement with the United States after negotiations were delayed by concerns over patient privacy, medical data sharing and access to biological samples. The agreement is intended to support health services in the southern African country over the next five years.
The deal was concluded after controversial provisions relating to the sharing of patient information and biological specimens with the United States were removed or revised. Zambian officials have also stressed that the health funding agreement is separate from negotiations over the country’s mineral resources.
The agreement reflects a wider shift in how the administration of US President Donald Trump is providing health assistance to African countries, following the dismantling of the United States Agency for International Development (USAID).

WHY THE NEGOTIATIONS STALLED

Earlier negotiations between Lusaka and Washington stalled over concerns about the protection of sensitive health information and a reported attempt to link the funding to access to Zambia’s critical minerals.
Patient records can contain confidential information about individuals’ medical conditions, treatments and other personal details. Biological specimens, such as blood and tissue samples, can also be used for medical research, disease surveillance and the development of diagnostic tests and treatments.
Zambia was concerned about the conditions under which such information and specimens could be shared with foreign organisations. These concerns became a major obstacle to reaching an agreement.
The revised deal seeks to limit the information Zambia provides to what is needed to monitor and evaluate health programmes funded by the United States.

WHAT ZAMBIA AGREED TO ON DATA SHARING

Zambia’s Health Minister, Roma Chilengi, said information sharing would be restricted to data required to monitor and evaluate US-funded health programmes.
This means that information would be used to assess whether the funded projects are achieving their intended objectives, including whether resources are reaching the appropriate programmes and whether health interventions are producing measurable results.
However, the question of how health information is collected, protected, stored and shared remains important. The United States has said that health data and biological specimens could be provided to as many as 10 American non-governmental entities for the development of diagnostic tools and medical treatments.
Such work can contribute to medical research, but it also raises questions about consent, privacy, ownership of biological samples and how the benefits of research are shared.
The final terms governing these issues will be important in determining how the agreement operates in practice.

HOW MUCH MONEY WILL THE AGREEMENT PROVIDE?

The United States is committing $1.5 billion under the agreement, while the combined contribution from both countries is expected to reach approximately $3.6 billion over five years.
The funding is intended to support health services in Zambia. Its potential impact will depend on how the money is allocated, the programmes it supports and the ability of health authorities to deliver services effectively.
Health financing can help governments strengthen disease prevention, improve access to treatment, support medical facilities and maintain essential public health programmes. The agreement’s implementation will therefore be closely watched by health workers and communities that depend on publicly supported services.
The combined figure of $3.6 billion represents the reported total contribution from both countries, rather than funding provided by the United States alone.

WHY THE UNITED STATES CHANGED ITS AID APPROACH

The agreement comes as the Trump administration pursues bilateral health financing arrangements with African governments following the dismantling of USAID.
Under this approach, African countries are expected to increase their own spending on health services gradually, while the United States phases out some of its assistance over time.
The policy is intended to encourage recipient countries to take greater financial responsibility for their health systems. However, the transition also raises questions about whether national budgets can replace external funding quickly enough to maintain existing services.
For countries that rely on international support for disease control, medicines, medical equipment and public health programmes, the timing and scale of any reduction in assistance can have significant consequences.

PREVIOUS DISPUTES OVER US HEALTH AID

In 2025, Washington announced that it was withdrawing $50 million in annual health assistance to Zambia. The US government attributed the decision to what it described as “systemic theft” of donated medicines and medical supplies.
That dispute formed part of the difficult background to the current negotiations. The new agreement offers a framework for continued health financing, but it also places renewed attention on accountability, transparency and the management of donated resources.
For Zambia, the challenge will be to secure the benefits of international assistance while protecting confidential health information and ensuring that money and supplies are used for their intended purposes.

OTHER AFRICAN COUNTRIES HAVE RAISED SIMILAR CONCERNS

Zambia is not the only African country to question the terms of proposed US health agreements. Ghana and Zimbabwe have also rejected arrangements over data-sharing demands, while at least nine other African countries have reportedly accepted the condition.
These responses highlight the difficult balance governments face when negotiating foreign health assistance. Funding can help support essential services, but governments must also consider the protection of citizens’ personal information, national interests and the long-term sustainability of their health systems.
The debate is particularly significant where medical data and biological specimens may be used by external organisations for research and commercial development.

MINERAL RESOURCES TO BE NEGOTIATED SEPARATELY

Zambian officials have said the health financing deal is not linked to an agreement granting the United States access to the country’s mineral resources.
Zambia has substantial mineral wealth, including copper and other resources important to global manufacturing and energy technologies. Any separate negotiations over these resources are expected to proceed independently of the health agreement.
Keeping the two issues separate is significant because the earlier negotiations reportedly stalled partly over concerns that health assistance was being linked to access to critical minerals.

WHAT HAPPENS NEXT?

The focus will now shift to implementing the five-year agreement, monitoring how the funding is spent and ensuring that health programmes deliver practical benefits to the population.
Both governments will also need to follow the agreed rules on data sharing and programme evaluation. Clear safeguards will be important to prevent the misuse of sensitive information and to establish how biological specimens and research findings may be used.
For Zambia, the agreement offers continued financial support for health services while leaving unresolved questions about the wider direction of US assistance to Africa. Its long-term impact will depend on whether the funding improves healthcare delivery, whether privacy protections are respected and whether Zambia can gradually strengthen domestic financing as foreign assistance changes.